Additional file 5: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Additional file 1: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Figure S1. Flow chart illustrating the sample inclusion/exclusion process in malignant cores. A) 5mC...

Additional file 1: of PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

Marie-Christine Heinrich (5327549)
Cosima Gรถbel (5327561)
Martina Kluth (747911)
Christian Bernreuther (227240)
Charlotte Sauer (4279735)
Cornelia Schroeder (5327552)
Christina Mรถller-Koop (5327558)
Claudia Hube-Magg (747910)
Patrick Lebok (747913)
Eike Burandt (514480)
Guido Sauter (124861)
Ronald Simon (997)
Hartwig Huland (596351)
Markus Graefen (596350)
Hans Heinzer (747915)
Thorsten Schlomm (201659)
Asmus Heumann (4741422)

May 2018

Figure S1. Kaplan-Meier plot of prostate specific antigen (PSA) recurrence and PSCA expression strat...

Additional file 7: Table S6. of Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Keisuke Takeda (3572375)
Noboru Hara (3572384)
Tsutomu Nishiyama (3572387)
Masayuki Tasaki (3572378)
Fumio Ishizaki (3572381)
Yoshihiko Tomita (2511928)

May 2016

Ct values of quantitative PCR in LNCaP cells cultured with dihydrotestosterone- and hydroxyflutamide...

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 4: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S2. Fold-change in phospho-γH2A.X levels following PSMA-RLT. Mean ± SD are given. After 48 h, ...

Additional file 1: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Figure S1. PSMA expression kinetics following ARB. C4-2 tumors were induced in Scid mice. Mice recei...

Additional file 1: of Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

B. Meller (3767254)
F. Bremmer (3767257)
C. Sahlmann (3767242)
S. Hijazi (3767245)
C. Bouter (3767263)
L. Trojan (3767251)
J. Meller (3767248)
P. Thelen (3767260)

November 2015

68 Ga-HBED-CC Radio-HPLC. Quality control of a regular Ga-HBED-CC synthesis. Radiochemical purity wa...

Additional file 5: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Figure S1. Migration and invasion assays of the five PCa cell lines. (A–B) Representative images and...

Additional file 4: of Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

Constantinos Zamboglou (364809)
Benedikt Thomann (5096807)
Khodor Koubar (5162633)
Peter Bronsert (3410321)
Tobias Krauss (5162627)
Hans Rischke (5096813)
Ilias Sachpazidis (5162624)
Vanessa Drendel (700868)
Nasr Salman (5162636)
Kathrin Reichel (5162630)
Cordula Jilg (3770989)
Martin Werner (281835)
Philipp Meyer (2042710)
Michael Bock (541214)
Dimos Baltas (5096810)
Anca Grosu (4637779)

May 2018

Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...

Additional file 5: Table S4. of Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Keisuke Takeda (3572375)
Noboru Hara (3572384)
Tsutomu Nishiyama (3572387)
Masayuki Tasaki (3572378)
Fumio Ishizaki (3572381)
Yoshihiko Tomita (2511928)

May 2016

Ct values of quantitative PCR in LNCaP cells cultured with dihydrotestosterone-added media. (DOC 31 ...

Additional file 4: of Genomic analysis of DNA repair genes and androgen signaling in prostate cancer

Kasey Jividen (5846180)
Katarzyna Kedzierska (5846183)
Chun-Song Yang (5846186)
Karol Szlachta (5511017)
Aakrosh Ratan (279792)
Bryce Paschal (5846189)

October 2018

Figure S1. Standard GSEA plots of the HALLMARK_ANDROGEN_RESPONSE gene set. Analysis included pre-ran...

Additional file 1: of Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007

Stephanie Robu (5096471)
Alexander Schmidt (68515)
Matthias Eiber (4896889)
Margret Schottelius (1816879)
Thomas GĂźnther (5096495)
Behrooz Hooshyar Yousefi (5096468)
Markus Schwaiger (10806)
Hans-JĂźrgen Wester (5096492)

April 2018

Supporting information contains the description of the chemical synthesis and radiolabeling of all c...

Additional file 8: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Table S1B. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...

Additional file 1 of PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

Hui Wang (11310555)
Thomas Amiel (11310558)
Christoph Würnschimmel (11310561)
Thomas Langbein (11310564)
Katja Steiger (831771)
Isabel Rauscher (8396568)
Thomas Horn (10130)
Tobias Maurer (4896895)
Wolfgang Weber (1390167)
Hans-Juergen Wester (43799)
Karina Knorr (11310567)
Matthias Eiber (4896889)

August 2021

Additional file 1. Supplementary files. Supplementary table 1. Distribution of pT and miT. Supplemen...

Additional file 1 of 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani (4710744)
Michael Hofman (4054939)
Tony Mulcahy (4710741)
Scott Williams (27584)
Declan Murphy (3480083)
Bimal Parameswaran (4710747)
Rodney Hicks (4054942)

December 2017

Table S1 Characteristics and modality based results in BCR patients. Table S2 Characteristics and mo...

Additional file 1: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Figure S1. Flow chart illustrating the sample inclusion/exclusion process in malignant cores. A) 5mC...

Additional file 1: of PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

Marie-Christine Heinrich (5327549)
Cosima Gรถbel (5327561)
Martina Kluth (747911)
Christian Bernreuther (227240)
Charlotte Sauer (4279735)
Cornelia Schroeder (5327552)
Christina Mรถller-Koop (5327558)
Claudia Hube-Magg (747910)
Patrick Lebok (747913)
Eike Burandt (514480)
Guido Sauter (124861)
Ronald Simon (997)
Hartwig Huland (596351)
Markus Graefen (596350)
Hans Heinzer (747915)
Thorsten Schlomm (201659)
Asmus Heumann (4741422)

May 2018

Figure S1. Kaplan-Meier plot of prostate specific antigen (PSA) recurrence and PSCA expression strat...

Additional file 7: Table S6. of Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Keisuke Takeda (3572375)
Noboru Hara (3572384)
Tsutomu Nishiyama (3572387)
Masayuki Tasaki (3572378)
Fumio Ishizaki (3572381)
Yoshihiko Tomita (2511928)

May 2016

Ct values of quantitative PCR in LNCaP cells cultured with dihydrotestosterone- and hydroxyflutamide...

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 4: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S2. Fold-change in phospho-γH2A.X levels following PSMA-RLT. Mean ± SD are given. After 48 h, ...

Additional file 1: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Figure S1. PSMA expression kinetics following ARB. C4-2 tumors were induced in Scid mice. Mice recei...

Additional file 1: of Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

B. Meller (3767254)
F. Bremmer (3767257)
C. Sahlmann (3767242)
S. Hijazi (3767245)
C. Bouter (3767263)
L. Trojan (3767251)
J. Meller (3767248)
P. Thelen (3767260)

November 2015

68 Ga-HBED-CC Radio-HPLC. Quality control of a regular Ga-HBED-CC synthesis. Radiochemical purity wa...

Additional file 5: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Figure S1. Migration and invasion assays of the five PCa cell lines. (A–B) Representative images and...

Additional file 4: of Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

Constantinos Zamboglou (364809)
Benedikt Thomann (5096807)
Khodor Koubar (5162633)
Peter Bronsert (3410321)
Tobias Krauss (5162627)
Hans Rischke (5096813)
Ilias Sachpazidis (5162624)
Vanessa Drendel (700868)
Nasr Salman (5162636)
Kathrin Reichel (5162630)
Cordula Jilg (3770989)
Martin Werner (281835)
Philipp Meyer (2042710)
Michael Bock (541214)
Dimos Baltas (5096810)
Anca Grosu (4637779)

May 2018

Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...

Additional file 5: Table S4. of Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Keisuke Takeda (3572375)
Noboru Hara (3572384)
Tsutomu Nishiyama (3572387)
Masayuki Tasaki (3572378)
Fumio Ishizaki (3572381)
Yoshihiko Tomita (2511928)

May 2016

Ct values of quantitative PCR in LNCaP cells cultured with dihydrotestosterone-added media. (DOC 31 ...

Additional file 4: of Genomic analysis of DNA repair genes and androgen signaling in prostate cancer

Kasey Jividen (5846180)
Katarzyna Kedzierska (5846183)
Chun-Song Yang (5846186)
Karol Szlachta (5511017)
Aakrosh Ratan (279792)
Bryce Paschal (5846189)

October 2018

Figure S1. Standard GSEA plots of the HALLMARK_ANDROGEN_RESPONSE gene set. Analysis included pre-ran...

Additional file 1: of Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007

Stephanie Robu (5096471)
Alexander Schmidt (68515)
Matthias Eiber (4896889)
Margret Schottelius (1816879)
Thomas GĂźnther (5096495)
Behrooz Hooshyar Yousefi (5096468)
Markus Schwaiger (10806)
Hans-JĂźrgen Wester (5096492)

April 2018

Supporting information contains the description of the chemical synthesis and radiolabeling of all c...

Additional file 8: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Table S1B. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...

Additional file 1 of PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

Hui Wang (11310555)
Thomas Amiel (11310558)
Christoph Würnschimmel (11310561)
Thomas Langbein (11310564)
Katja Steiger (831771)
Isabel Rauscher (8396568)
Thomas Horn (10130)
Tobias Maurer (4896895)
Wolfgang Weber (1390167)
Hans-Juergen Wester (43799)
Karina Knorr (11310567)
Matthias Eiber (4896889)

August 2021

Additional file 1. Supplementary files. Supplementary table 1. Distribution of pT and miT. Supplemen...

Additional file 1 of 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani (4710744)
Michael Hofman (4054939)
Tony Mulcahy (4710741)
Scott Williams (27584)
Declan Murphy (3480083)
Bimal Parameswaran (4710747)
Rodney Hicks (4054942)

December 2017

Table S1 Characteristics and modality based results in BCR patients. Table S2 Characteristics and mo...

Additional file 1: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Figure S1. Flow chart illustrating the sample inclusion/exclusion process in malignant cores. A) 5mC...

Additional file 1: of PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

Marie-Christine Heinrich (5327549)
Cosima Gรถbel (5327561)
Martina Kluth (747911)
Christian Bernreuther (227240)
Charlotte Sauer (4279735)
Cornelia Schroeder (5327552)
Christina Mรถller-Koop (5327558)
Claudia Hube-Magg (747910)
Patrick Lebok (747913)
Eike Burandt (514480)
Guido Sauter (124861)
Ronald Simon (997)
Hartwig Huland (596351)
Markus Graefen (596350)
Hans Heinzer (747915)
Thorsten Schlomm (201659)
Asmus Heumann (4741422)

May 2018

Figure S1. Kaplan-Meier plot of prostate specific antigen (PSA) recurrence and PSCA expression strat...

Additional file 7: Table S6. of Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Keisuke Takeda (3572375)
Noboru Hara (3572384)
Tsutomu Nishiyama (3572387)
Masayuki Tasaki (3572378)
Fumio Ishizaki (3572381)
Yoshihiko Tomita (2511928)

May 2016

Ct values of quantitative PCR in LNCaP cells cultured with dihydrotestosterone- and hydroxyflutamide...

Additional file 5: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Abstract

Extracted data

Additional file 5: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Abstract

Extracted data

Related items

Related items